Vardenafil oral jellies as a potential approach for management of pediatric irritable bowel syndrome
Irritable bowel syndrome (IBS); a widespread disorder in gastrointestinal tract especially in children, burdens their healthcare systems and upsets families. Great attention was paid to understand the pathophysiological cause of disorder. However, developing a convenient treatment especially for chi...
Main Authors: | Eman Gomaa, Margrit M. Ayoub |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-09-01
|
Series: | Saudi Pharmaceutical Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S131901642100147X |
Similar Items
-
Vardenafil Oral Dispersible Films (ODFs) with Advanced Dissolution, Palatability, and Bioavailability
by: Heba A. Abou-Taleb, et al.
Published: (2022-02-01) -
Isolation and identification of a novel vardenafil analogue, propoxy-vardenafil, found as an adulterant in a health supplement
by: Jian Sun, et al.
Published: (2023-06-01) -
Vardenafil Reduces Testicular Damage Following Ischemia/Reperfusion Injury in Rats
by: Bulent Erol, et al.
Published: (2009-07-01) -
Oral and fecal microbiota in patients with diarrheal irritable bowel syndrome
by: Binbin Tang, et al.
Published: (2023-01-01) -
Vardenafil Activity in Lung Fibrosis and In Vitro Synergy with Nintedanib
by: Michael H. Bourne, et al.
Published: (2021-12-01)